Anagrelide Hydrochloride (Carilion Materials Management)


Welcome to the PulseAid listing for the Anagrelide Hydrochloride drug offered from Carilion Materials Management. This Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Carilion Materials Management
NON-PROPRIETARY NAME: Anagrelide Hydrochloride
SUBSTANCE NAME: ANAGRELIDE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2005-04-18
END MARKETING DATE: 0000-00-00


Anagrelide Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAnagrelide Hydrochloride from Carilion Materials Management
LABELER NAME: Carilion Materials Management
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 2005-04-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68151-2959_691914ba-6279-4b7c-9908-e258330fdb5b
PRODUCT NDC: 68151-2959
APPLICATION NUMBER: ANDA076468

Other ANAGRELIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalAnagrelide Hydrochloride
Carilion Materials ManagementAnagrelide Hydrochloride
Physicians Total Care, Inc.Anagrelide Hydrochloride
Shire US Manufacturing Inc.Agrylin
Teva Pharmaceuticals USA, IncAnagrelide Hydrochloride
Torrent Pharmaceuticals Limitedanagrelide